The liver is involved in the regulation of serum levels of IgA through the selective transport of circulating IgA into the bile, and in the removal of IgA-containing immune complexes and their transport through the hepatocytes into the bile. Recent evidence indicates that several types of receptors on hepatocytes are involved in this transport process. In addition to """"""""secretory component"""""""", a glycoprotein identified as a receptor for IgA on epithelial cells and on rodent hepatocytes, glycoprotein receptors and an as yet unidentified receptor specific for polymeric IgA are involved. The mechanisms of binding of mouse and human IgA of two subclasses and different molecular forms by mouse and human liver will be investigated in vitro. The specificity of the IgA receptor(s) will be determined by competitive binding assays to a particulate fraction of liver homogenates, to isolated plasma membranes, and to detergent-solubilized, affinity chromatography purified IgA receptors. The role of carbohydrates and the type of liver cells involved in the binding of IgA will be examined. Transport of immune complexes that contain in addition to IgA, also IgM or IgG antibodies will be examined with respect to their mechanism of hepatobiliary transport: The ability of immune complexes containing IgA, IgG or IgM to induce a subsequent immune response will be investigated. The fate and organ distribution of immune complexes that contain various immunoglobulin classes will be investigated in animals with mechanically impaired bile outflow or chemically induced liver damage. The planned studies may elucidate the incompletely characterized functions of serum IgA, which in humans represents an immunoglobulin class produced in larger quantities than IgG and IgM.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK028537-05
Application #
3228879
Study Section
Pathology B Study Section (PTHB)
Project Start
1982-01-01
Project End
1987-12-31
Budget Start
1986-01-01
Budget End
1986-12-31
Support Year
5
Fiscal Year
1986
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
School of Medicine & Dentistry
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Renegar, K B; Jackson, G D; Mestecky, J (1998) In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA. J Immunol 160:1219-23
Tomana, M; Matousovic, K; Julian, B A et al. (1997) Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 52:509-16
Endo, T; Radl, J; Mestecky, J (1997) Structural differences among serum IgA proteins of chimpanzee, rhesus monkey and rat origin. Mol Immunol 34:557-65
Takahashi, T; Iwase, T; Takenouchi, N et al. (1996) The joining (J) chain is present in invertebrates that do not express immunoglobulins. Proc Natl Acad Sci U S A 93:1886-91
Tomana, M; Julian, B A; Waldo, F B et al. (1995) IgA nephropathy. A disease of incomplete IgA 1 glycosylation? Adv Exp Med Biol 376:221
Mestecky, J; Hashim, O H; Tomana, M (1995) Alterations in the IgA carbohydrate chains influence the cellular distribution of IgA1. Contrib Nephrol 111:66-71;discussion 71-2
Wu, H Y; White, P L; Beagley, K W et al. (1995) IgA production and transport in the murine liver after mucosal immunization. Adv Exp Med Biol 371B:1061-6
Stenberg, L; O'Toole, P W; Mestecky, J et al. (1994) Molecular characterization of protein Sir, a streptococcal cell surface protein that binds both immunoglobulin A and immunoglobulin G. J Biol Chem 269:13458-64
Nikolova, E B; Tomana, M; Russell, M W (1994) The role of the carbohydrate chains in complement (C3) fixation by solid-phase-bound human IgA. Immunology 82:321-7
Wold, A E; Motas, C; Svanborg, C et al. (1994) Lectin receptors on IgA isotypes. Scand J Immunol 39:195-201

Showing the most recent 10 out of 29 publications